Pfizer
Nitesh Saha is an accomplished professional in data analytics and supply chain management, currently serving as the Director of Data Analytics for Network Design and Performance at Pfizer Global Supply since January 2016. Prior to this role, Nitesh held the position of Senior Manager in Global Analytics at Pfizer and served as an Advanced Analytics Manager and Customer Analytics Manager at GlaxoSmithKline from August 2010 to December 2015. Nitesh began the career as a Statistician at IMS Health from January 2006 to August 2010, and earlier worked in a similar capacity at Marshall & Swift/Boeckh in 2005. Nitesh holds a PhD in Economics from Utah State University, a Master of Science in Economics with a focus on Econometrics and Operations Research from the University of Calcutta, and a Bachelor of Science in Economics, Mathematics, and Political Science from Krishnath College.
This person is not in any offices
Pfizer
606 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.